ZKSCAN3 and metabolic disease: Within metabolic disorders, including T2DM-AS, high-glucose stress activates ZKSCAN3, leading to its nuclear retention and subsequent inhibition of macrophage autophagy, which accelerates atherosclerotic plaque formation [117].